Sibylla Biotech Raises €23M in Series A Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Ward Capoen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Sibylla Biotech today announced the successful close of its €23 million Series A financing round to fund the further development of its Pharmacological Protein Inactivation by Folding Intermediate
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
V-Bio Ventures raises EUR 110 million for its second fund and expands teamGhent, Belgium, 31 March 2022 – V-Bio Ventures announced the final closing of its second fund, V-Bio Fund 2, having raised EUR 110 million euro and exceeding its target of EUR 100 million.Together with their first fund, V-Bio Fund 1, V-B...